Patents by Inventor Harald Stork

Harald Stork has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Phenoxyalkylcarboxylic acid compounds and therapeutic compositions
    Patent number: 4153728
    Abstract: Novel phenoxyalkylcarboxylic acid compounds of the formula ##STR1## wherein B is a valency bond or a straight-chained or branched, saturated or unsaturated hydrocarbon radical containing up to 3 carbon atoms;N is 1 or 2 andR.sub.1, r.sub.2 and R.sub.3 are hydrogen or lower alkyl; and the pharmacologically compatible salts thereof; have been found to be outstandingly effective in lowering the serum lipid level and the cholesterol level in mammals without inducing undesired side effects and to possess excellent thrombocyte-aggregation inhibiting activity.
    Type: Grant
    Filed: October 18, 1976
    Date of Patent: May 8, 1979
    Assignee: Boehringer Mannheim GmbH
    Inventors: Hans P. Wolff, Ernst-Christian Witte, Max Thiel, Harald Stork, Egon Roesch
  • Therapeutic compositions and methods employing N(6)-disubstituted adenosine compounds
    Patent number: 4016262
    Abstract: N(6)-disubstituted adenosine compounds of the formula: ##STR1## wherein R.sub.1 is alkenyl, cycloalkenyl or cycloalkenyl-alkyl; andR.sub.2 is alkenyl, cycloalkenyl, straight or branched-chain alkyl, cycloalkyl, bicycloalkyl, alkyl-cycloalkyl, or alkyl-bicycloalkyl;And the pharmacologically compatible salts thereof; exhibit outstanding anti-lipolytic, anti-hyperlipaemic and anti-hypercholesterolaemic action.
    Type: Grant
    Filed: May 30, 1975
    Date of Patent: April 5, 1977
    Assignee: Boehringer Mannheim G.m.b.H.
    Inventors: Erich Fauland, Wolfgang Kampe, Kurt Stach, deceased, by Werner Plattner, executor, Harald Stork, Karl Dietmann
  • Heterocyclic-substituted nebularin compounds
    Patent number: 3988317
    Abstract: New heterocyclic-substituted nebularin compounds of the formula: ##SPC1##WhereinR.sub.1 is hydrogen, halogen or amino;R.sub.2 and R.sub.3, which may be the same or different, are hydrogen, hydroxyl, lower alkyl, alkoxy or hydroxyalkyl; andn is 2 or 3 or, when R.sub.1 is a halogen atom or an amino group, n can also be 1; and the pharmacologically compatible salts thereof;Are outstandingly effective in reducing body fat levels in mammals, e.g., the concentration of free fatty acids, of triglycerides and of cholesterol in serum.
    Type: Grant
    Filed: November 2, 1972
    Date of Patent: October 26, 1976
    Assignee: Boehringer Mannheim G.m.b.H.
    Inventors: Wolfgang Kampe, Klaus Koch, Kurt Stach, Harald Stork, Felix Helmut Schmidt
  • N(6)-disubstituted adenoisine compounds and therapeutic compositions
    Patent number: 3966916
    Abstract: New N(6)-disubstituted adenosine compound of the formula ##SPC1##WhereinR.sub.1 is lower alkyl substituted by at least one of hydroxyl, alkoxy or acyloxy; or is cycloalkyl or straight-chained or branched lower alkenyl;R.sub.2 and R.sub.3 are hydrogen, halogen, or nitro or lower alkyl, alkoxy or alkylthio andR.sub.4 is hydrogen or acyl; when R.sub.4 is acyl, R.sub.1 can also be lower alkyl;And the pharmacologicaly compatible salts thereof; exhibits shown anti-lipolytic, anti-hyperlipaemic and anti-hypercholesterolaemic action.
    Type: Grant
    Filed: November 21, 1974
    Date of Patent: June 29, 1976
    Assignee: Boehringer Mannheim G.m.b.H.
    Inventors: Wolfgang Kampe, Erich Fauland, Kurt Stach, Harald Stork, Felix Helmut Schmidt